In Russia, said they found a cure for liver cirrhosis
Scientists Institute of Pharmacology, Russian Academy of Medical Sciences (Tomsk), together with the experts' futures Scientific Management "(Novosibirsk) have created a unique agent-based medicine for the regeneration of liver cirrhosis
According to RIA Novato news agency comments the deputy director of the institute Vadim Zhdanov, a new drug goes to the pharmacy may have five or six years,
It is known that liver cirrhosis - a serious illness, which is among the ten leading causes of death of patients in many developed countries. In this disease in the organ tissue is gradually formed connective (scar) tissue, which leads eventually to the development of liver failure.
"Develop a substance created by using radiation technology of synthesis, by which it has unique properties. This immobilized enzyme capable of stimulating liver regeneration. It will activate the stem cells of the liver, and due to this scar tissue will be replaced with a healthy body "- said Zhdanov.
According to him, unique substance created by the mechanism of action in the world. "This is a breakthrough because the existing drugs, which belong to the group hepatoprotectors, protect liver cells from destruction, but their action is not intended to replace the already altered tissue (scar) of healthy liver tissue," - said the MD.
Zhdanov also said that at present conducted preclinical studies of substance: "The research work currently being carried out on the research agenda of Medical Sciences and at the expense of the institute, and the production of pilot batches of the drug - at the expense of our partners - LLC" Scientific futures management "(Novosibirsk) . We have also applied for funding for further work in one of the federal programs. If the money will be allocated, and this is 33 million rubles in the initial stage, then in five years or six drugs may reach the end consumer. "
He said that before the drug is on pharmacy shelves, the scientists will conduct long-term studies and drug registration.
0 comments:
Post a Comment